Randomized phase II/III trial of post-operative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin in high-risk patients with squamous cell carcinoma of head and neck: Japan Clinical Oncology Group study (JCOG1008) - Kunieda, F; Kiyota, N; Tahara, M (Japanese Journal of Clinical Oncology, 2014)
. doi:10.1093/jjco/hyu067